New York, NY -- (SBWIRE) -- 01/08/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Atmel Corporation(NASDAQ:ATML), MGIC Investment Corp.(NYSE:MTG), Stereotaxis Inc(NASDAQ:STXS),Exelixis, Inc.(NASDAQ:EXEL)
Atmel Corporation(NASDAQ:ATML) reported gain 1.02% and closed at $7.93 with the total traded volume of 5.34M shares. Its market capitalization is $3.38B. The stock has a 52-week high price of 8.40 and its 52-week low was recorded at $5.89
Atmel Corporation (Atmel) is engaged in designing, developing and supplying of microcontrollers. Atmel offers a portfolio of touch products, which integrate its microcontrollers with touch-focused intellectual property (IP).
What ATML Charts Are Signaling for Traders? Find Out Here
MGIC Investment Corp.(NYSE:MTG) gain 1.22% and ended at $8.33.The total traded volume was 5.34M shares and market capitalization arrived at $52.81B. The stock has a 52-week high price of $8.69 and its 52-week low was recorded at $2.36.
MGIC Investment Corporation (MGIC) is a holding company and through wholly owned subsidiaries is a private mortgage insurer in the United States.
Is MTG Buy After The Recent Price Movement? Find Out Here
Stereotaxis Inc(NASDAQ:STXS)’s reported the increase of 12.50% to close at $4.50 with the overall traded volume of 5.12M shares. Its market capitalization on last close reached to $78.62 million. Its intraday-low price was $4.41 and its hit its day's highest price at $5.24
Stereotaxis, Inc. is a United States-based company that develops probes, devices, therapeutic and magnetic surgery delivery systems.
Should STXS a Buy or Sell Now? Find Out Here
Exelixis, Inc.(NASDAQ:EXEL) increase 0.51% settle at $6.84. Its total traded volume during last trading session was 5.11M shares. The 52 week range of the stock remained $4.32 - $7.27, while its day's lowest price was $6.83 and its hit its day's highest price at $7.27.
Exelixis, Inc. (Exelixis) is a biotechnology company engaged in developing small molecule therapies for the treatment of cancer.
What EXEL Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)